Will Spooren is section head of behavioral pharmacology and preclinical imaging at Hoffman-La Roche and coordinator of EU-AIMS.
Will Spooren
Head of behavioral pharmacology and preclinical imaging
F. Hoffmann-La Roche
From this contributor
Questions for Will Spooren: Paving a path to autism drugs
A European initiative that aims to provide a framework for clinical trials in autism has developed tools to track treatment responses.
Questions for Will Spooren: Paving a path to autism drugs
Explore more from The Transmitter
Astrocytes orchestrate oxytocin’s social effects in mice
The cells amplify oxytocin—and may be responsible for sex differences in social behavior, two preprints find.
Astrocytes orchestrate oxytocin’s social effects in mice
The cells amplify oxytocin—and may be responsible for sex differences in social behavior, two preprints find.
Neuro’s ark: Spying on the secret sensory world of ticks
Carola Städele, a self-proclaimed “tick magnet,” studies the arachnids’ sensory neurobiology—in other words, how these tiny parasites zero in on their next meal.
Neuro’s ark: Spying on the secret sensory world of ticks
Carola Städele, a self-proclaimed “tick magnet,” studies the arachnids’ sensory neurobiology—in other words, how these tiny parasites zero in on their next meal.
Autism in old age, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 2 March.
Autism in old age, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 2 March.